key: cord-0893167-9a562d0y authors: Ueberham, Laura; König, Sebastian; Pellissier, Vincent; Hohenstein, Sven; Meier-Hellmann, Andreas; Kuhlen, Ralf; Hindricks, Gerhard; Bollmann, Andreas title: Admission Rates and Care Pathways in Patients with Atrial Fibrillation during the COVID-19 Pandemic – Insights from the German-wide Helios Hospital Network date: 2021-03-16 journal: Eur Heart J Qual Care Clin Outcomes DOI: 10.1093/ehjqcco/qcab011 sha: 4cb7bd01f244512fc5339b08ef2aecc57e24ee0c doc_id: 893167 cord_uid: 9a562d0y INTRODUCTION: Several reports indicate lower rates of emergency admissions in the cardiovascular sector and reduced admissions of patients with chronic diseases during the COVID-19 pandemic. The aim of this study was therefore to evaluate numbers of admissions in incident and prevalent atrial fibrillation and flutter (AF) and to analyze care pathways in comparison to 2019. METHODS: A retrospective analysis of claims data of 74 German Helios hospitals was performed to identify consecutive patients hospitalized with a main discharge diagnosis of AF. A study period including the start of the German national protection phase (13th March 2020 to 16th July 2020) was compared to a previous year control cohort (15th March 2019 to 18th July 2019), with further sub-division into early and late phase. Incidence rate ratios (IRR) were calculated. Numbers of admission per day (A/day) for incident and prevalent AF and care pathways including readmissions, numbers of transesophageal echocardiogram (TEE), electrical cardioversion (CV) and catheter ablation (CA) were analyzed. RESULTS: During the COVID-19 pandemic, there was a significant decrease of total AF admissions both in the early (44.4 vs. 77.5 A/day, IRR 0.57 [95% CI 0.54–0.61], p < 0.01) and late phase (59.1 vs. 63.5 A/day, IRR 0.93 [95% CI 0.90–0.96], p < 0.01), length of stay was significantly shorter (3.3 ± 3.1 nigths vs. 3.5 ± 3.6 nigths, p < 0.01), admissions were more frequently in high volume centers (77.0% vs. 75.4%, p = 0.02) and frequency of readmissions was reduced (21.7% vs. 23.6%, p < 0.01) compared to the previous year. Incident AF admission rates were significantly lower both in the early (21.9 admission per day vs. 41.1 A/day, IRR 0.53 [95% CI 0.48 − 0.58]) and late phase (35.5 vs. 39.3 A/day, IRR 0.90 [95% CI 0.86 − 0.95]), whereas prevalent admissions were only lower in the early phase (22.5 vs 36.4 A/day IRR 0.62 [95% CI 0.56 − 0.68]), but not in the late phase (23.6 vs. 24.2 A/day IRR 0.97 [95% CI 0.92 − 1.03]). Analysis of care pathways showed reduced numbers of TEE during the early phase (34.7% vs. 41.4%, OR 0.74 [95% CI 0.64 − 0.86], p < 0.01), but not during the late phase (39.9% vs. 40.2%, OR 0.96 [95% CI 0.88 − 1.03], p = 0.26). Numbers of CV were comparable during early (40.6% vs. 39.7%, OR 1.08 [95% CI 0.94 − 1.25], p = 0.27) and late phase (38.6% vs. 37.5%, OR 1.06 [95% CI 0.98 − 1.14], p = 0.17), compared to the previous year, respectively. Numbers of CA were comparable during the early phase (21.6% vs. 21.1%, OR 0.98 [95% CI 0.82 − 1.17], p = 0.82) with a distinct increase during the late phase (22.9% vs. 21.5%, OR 1.05 [95% CI 0.96–1.16], p = 0.28). CONCLUSION: During the COVID-19 pandemic, AF admission rates declined significantly, with a more pronounced reduction in incident than in prevalent AF. Overall AF care was maintained during early and late pandemic phase with only minor changes, namely less frequent use of TEE. Confirmation of these findings in other study populations as well as identification of underlying causes are required to ensure optimal therapy in patients with AF during the COVID-19 pandemic. Introduction: Several reports indicate lower rates of emergency admissions in the cardiovascular sector and reduced admissions of patients with chronic diseases during the COVID-19 pandemic. The aim of this study was therefore to evaluate numbers of admissions in incident and prevalent atrial fibrillation and flutter (AF) and to analyze care pathways in comparison to 2019. Methods: A retrospective analysis of claims data of 74 German Helios hospitals was performed to identify consecutive patients hospitalized with a main discharge diagnosis of AF. A study period including the start of the German national protection phase (13th March 2020 to 16th July 2020 ) was Incident AF admission rates were significantly lower both in the early (21. 9 diseased and maintenance of usual medical care for patients without COVID-19. In the cardiovascular sector, several reports indicated lower rates of emergency admissions during the national lockdowns [1] [2] [3] and admissions of patients with chronic diseases were reported to be reduced as well [4] [5] [6] . Besides worries about delayed care in emergency situations, the decrease in admission rates may be also accompanied by underdiagnosis of relevant cardiac diseases causing only moderate to mild symptoms. For atrial fibrillation or atrial flutter (AF), a 47% lower incidence of patients with new-onset AF was reported in comparison to 2019 in a Danish nationwide registry 7 . The aim of this study was therefore to evaluate number of admissions in incident and prevalent AF and to analyze care pathways during the COVID-19 pandemic in comparison to the previous year in 74 Helios hospitals in Germany. We retrospectively analyzed claims data of 74 German hospitals for consecutive patients hospitalized in-or outpatients with a main discharge diagnosis of AF (ICD code I48, contains paroxysmal, Incident and prevalent AF Incident and prevalent AF was defined based on pre-existent AF diagnosis: patients without admission for atrial fibrillation (I48) as main or secondary diagnosis the 3 years prior to the starting date of the cohort were considered as presenting with incident, patients with a documented diagnosis of AF in the previous three years prevalent AF. Of note, it was possible that the same patient appears in both the two cohorts, or be admitted first for incident and then for prevalent AF. Admission type was classified as urgent or non-urgent. comparing the study period to each of the control periods or the early study period to the late study period were calculated using Poisson regression to model the number of hospitalizations per day. Number of admissions were calcuated for all combinations of (a) factor levels (i.e, age, sex, etc.), (b) hospitals, and (c) admission dates (of the corresponding period). These frequencies were used to create the dependent variables of the statistical models. The cumulative hospitalization deficit (CumHD) was computed as follows: difference between the expected and observed cumulative admission number for every week in the study period, expressed as a percentage (95% CI) of the cumulative expected number. The expected admission number was defined as the weekly average during the control period. The difference between the expected and observed cumulative admission number was assessed using a χ 2 test for the admission nadir defined as the week with the lowest admission number (3rd April -9th April 2020) and the last week of the study period (10th July -16th July 2020) 10 . Inferential statistics were based on generalized linear mixed models (GLMM) specifying hospitals as random factor 11, 12 . We employed Poisson GLMMs with log link function for count data. Effects were estimated with the lme4 package (version 1.1-21) 13 in the R environment for statistical computing (version 3.6.1, 64-bit build) (R Core Team 2019). In all models, we specified varying intercepts for the random factor. The IRR values for the different factor levels are based on the different models comparing the periods, respectively. Additionally, we employed another model for each factor with the variables (a) period, (b) treatment contrasts for the factor levels (for comparisons with the baseline level), and (c) the corresponding interactions. We report incidence-rate ratios (calculated by exponentiation of the negative of the regression coefficients) together with 95% confidence intervals (for the comparisons of the two periods) and p values for the interactions. For all tests we apply a twotailed 5% error criterion for significance. For the comparison of proportions of selected treatments, we used logistic GLMMs with logit link function. We report proportions, odds ratios (OR) together with 95% confidence intervals (95% CI) and The study cohort consisted of 7,001 and the control cohort of 8,424 patient cases ( Figure 1 , Table 1 ). Patients in the study cohort were more likely to have congestive heart failure (29.8% vs. 28,3%, Figure 1 ). The CumHD was -31% until the nadir week (3 rd April -9 th April 2020) and -17% until the final week of the study period (10 th July -16 th July 2020) in total AF admissions ( Figure 2 , Table 2 , Suppl. Figure 1 ). During the COVID-19 pandemic, there was a significant decrease of admissions with main diagnosis AF compared to the previous year in 72 Helios hospitals in Germany. admissions during three weeks of national lockdown in Denmark compared to 2019 7 . Of note, we were able to show that this was more pronounced during the early phase of the COVID-19 pandemic, the time including announcement of national lockdown and sanctions in very quick successions, and less accentuated during the late phase in April to July 2020. In contrast to the study by Holt and colleagues, we were also able to compare rates of incident and prevalent AF and showed that in particular hospital admissions of patients with incident AF were more reduced ( or 2) as the underlying causes of the decline in incident AF admission, although confirmation of these findings in other study populations is necessary. For cardiovascular disease, the use of telemedicine is promoted as a possibility to maintain usual care and ensure timely contact to the patient without infectious risk 15 . Peretto and colleagues described the setting of a multidisciplinary "myocarditis disease unit" for management of inpatient as well as outpatient visits 15 . Although unquestioned a timely concept, the problem of under-diagnosing due to reduced screening and therapy planning consultations has not been addressed yet. Search engine queries for chest pain and home care for chest pain have risen during the pandemic 16 and simultaneously, lower admission rates for ST-elevation myocardial infarction have been reported. Whether gadgets and applications capable of diagnosing AF would be beneficial for patients with mild symptoms and high threshold for self presentation, needs to be evaluated in the future as well. Our analysis showed a lower proportion of patients receiving TEE during the study period compared to the control period, exclusively driven by reduced TEE proportions during the early phase (34.7% vs. 41.4%, p<0.01). Of note, this could not be explained due to lower CHA2DS2-VASc scores in the study period. It is possible, however, that this is explained by direct droplet transmission and viral aerosolization during the examination and thus higher risk for infections in general during execution of examination. In addition, special safety precautions were recommended by the expert associations 17, 18 , altogether possibly leading to stricter indications. Furthermore, CV was more frequently used in prevalent AF patients compared to controls, accompanied by higher rates of CAs, although absolute numbers of all procedures were lower during the study phase compared to the previous year. Simultaneously, readmission rates were lower compared to 2019 both in incident and prevalent AF. Whether these effects are due to the stronger attempts to reduce avoidable medical re-contacts and thus reduce the risk for infection needs to be evaluated further. Interestingly, our analysis showed that during the late pandemic phase, numbers of CAs even exceeded The present study was based on claims data collected for reimbursement purposes. An intrinsic limitation of this approach is that results largely depend on quality of encoded diagnoses and procedures 19, 20 . Besides, detailed information about past medical history and comorbidities, physiognomy, referral status except for urgent or elective, results of diagnostic testing like imaging and lab values, medication including anticoagulation, compliance and treatment-related specific data were not available. In particular, information on prior outpatient treatments was not available and whether changes in admissions were related to a more effective management in the outpatient setting is unknown. A COVID-19 pandemic specific limitation is that, although diagnosis of proven infection lead to exclusion, there may be a relevant number of undetected infections. In addition, although numbers of COVID-19 infections were counted for each federal state respectively (Suppl. Thus, it is possible that the true number of incident AF admissions is even smaller, suggesting that a small proportion of patients was pre-diagnosed with AF in another institution. Of note, in this case incident AF admission rates would be even more reduced than in our current analysis. Furthermore, this analysis was based on administrative data of German Helios hospitals and our findings may not be generalizable to University or public hospitals other countries. During the COVID-19 pandemic, AF admission rates declined significantly, with a more pronounced reduction in incident compared to prevalent AF. Despite the aforementioned changes in AF care pathways, it has to be concluded that overall AF care was maintained during early and late pandemic phase with only minor changes. On the contrary, the lack of AF admission rates, especially in incident AF, needs more attention and concern. Confirmation of these findings in other study populations as well as identification of underlying causes are required to ensure optimal therapy in patients with AF during the COVID-19 pandemic. The data underlying this article will be shared on reasonable request to the corresponding author. the final week (10th July -16th July 2020). The cumulative expected hospitalization is computed using the weekly average for the same period in 2019 as a baseline. Tables Table 1 . Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China Treat all COVID 19-positive patients, but do not forget those negative with chronic diseases Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals The Untold Toll -The Pandemic's Effects on Patients without Covid-19 New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures Cumulative hospitalization deficit for cardiovascular disorders in Germany during the Covid-19 pandemic Mixed-effects modeling with crossed random effects for subjects and items A linear mixed model analysis of masked repetition priming Fitting Linear Mixed-Effects Models Usinglme4 Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe) Telemedicine in myocarditis: Evolution of a mutidisciplinary "disease Unit" at the time of COVID-19 pandemic Google Trends Insights Into Reduced Acute Coronary Syndrome Admissions During the COVID-19 Pandemic: Infodemiology Study Specific Considerations for the Protection of Patients and Echocardiography Service Providers When Performing Perioperative or Periprocedural Transesophageal Echocardiography during the 2019 Novel Coronavirus Outbreak: Council on Perioperative Echocardiography Supplement to the Statement of the American Society of Echocardiography Endorsed by the Society of Cardiovascular Anesthesiologists The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic Coding for Quality Measurement: the Relationship between Hospital Structural Characteristics and Coding Accuracy from the Perspective of Quality Measurement. Perspect Health Inf Manag Using routine comparative data to assess the quality of health care: understanding and avoiding common pitfalls. Quality and Safety in Health Care Cardioversion 2,188 (38.6%) 2,286 (37.5%)